Clinical and Hematological Characteristics of Pediatric Acute Lymphoblastic Leukemia at Tertiary Care General Hospital, Surabaya: A Descriptive Review from 2022–2024
International Journal of Drug Delivery Technology · 29.05.2026 · 16 (34s)
DOI: 10.25258/ijddt.16.34s.59 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.05.2026. Verfasst von Pramita Anindya Nugraheni und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Pediatric acute lymphoblastic leukemia (ALL) outcomes in low- and middle-income countries remain substantially worse than in high-income settings. This study describes the demographic, nutritional, and hematological profiles of pediatric ALL at a tertiary referral center in East Java, Indonesia (2022–2024), and highlights low-cost hematological ratios with potential clinical utility.
Methods
We conducted a retrospective descriptive analysis of 385 consecutive pediatric ALL cases diagnosed between 1 January 2022 and 31 December 2024 using electronic medical records and the Indonesian Pediatric Cancer Registry. Key variables included age, sex, nutritional status, full blood count at presentation, and derived indices: neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), hemoglobin-to-platelet ratio (HPR), and monocyte-to-neutrophil ratio (MNR). Vital status at last follow-up was recorded.
Results
Median age at diagnosis was 5.5 years (range 0.4–17.9); male patients comprised 64.2% (n=247). Underweight or severely underweight status affected 25.7% of the cohort. Median hemoglobin and platelet counts were 7.6 g/dL and 25 ×10^3/µL, respectively, indicating severe marrow failure at presentation. Median WBC was 7.7 ×10^3/µL (range up to 750.3 ×10^3/µL). Derived indices showed a median NLR of 0.1 and median HPR of 0.3. Overall mortality during the observation period was 48.1% (n=185).
Conclusion
Pediatric ALL in this tertiary Indonesian center presents with profound cytopenias, a high prevalence of undernutrition, and high mortality. Low-cost CBC-derived ratios (e.g., NLR, HPR) reflect severe marrow compromise and warrant further evaluation as early risk markers where advanced diagnostics are limited. Interventions targeting earlier diagnosis, nutritional optimization, and sepsis prevention are priorities to narrow the survival gap.
Zitieren
APA
Nugraheni, P. A., Cahyadi, A., Larasati, M. C. S., Andarsini, M. R., Ugrasena, I. D. G., & Adiwinoto, R. P. (2026). Clinical and Hematological Characteristics of Pediatric Acute Lymphoblastic Leukemia at Tertiary Care General Hospital, Surabaya: A Descriptive Review from 2022–2024. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.59
Vancouver
Nugraheni PA, Cahyadi A, Larasati MCS, Andarsini MR, Ugrasena IDG, Adiwinoto RP. Clinical and Hematological Characteristics of Pediatric Acute Lymphoblastic Leukemia at Tertiary Care General Hospital, Surabaya: A Descriptive Review from 2022–2024. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.59
BibTeX
@article{Nugraheni2026,
author = {Nugraheni, Pramita Anindya and Cahyadi, Andi and Larasati, Maria Christina Shanty and Andarsini, Mia Ratwita and Ugrasena, I Dewa Gede and Adiwinoto, Ronald Pratama},
title = {Clinical and Hematological Characteristics of Pediatric Acute Lymphoblastic Leukemia at Tertiary Care General Hospital, Surabaya: A Descriptive Review from 2022–2024},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {34s},
doi = {10.25258/ijddt.16.34s.59}
}
EUVIMED